top of page
Partnerships & Collaborations
Rambam Health Care Campus, Israel
Pharmachal and tier-1 Israeli trauma hospital Rambam are co-developing a new product for treating burns, wounds, haemophilia, and diabetic ulcers.
The collaboration will combine Pharmachal’s patented mini-emulsion “NDDS” drug delivery technology with a novel peptide drug developed at Rambam that has shown significant potential to speed up wound healing, coagulate bleeding, and encourage the formation of new blood vessels.
Magenta Investments, United Arab Emirates
Pharmachal is working with leading healthcare company Magenta Investments to distribute several products in the United Arab Emirates and GCC countries.
bottom of page